We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00804154
Recruitment Status : Recruiting
First Posted : December 8, 2008
Last Update Posted : March 6, 2018
National Institute of Neurological Disorders and Stroke (NINDS)
Sorrento Therapeutics, Inc.
Information provided by (Responsible Party):
National Institutes of Health Clinical Center (CC) ( National Institute of Dental and Craniofacial Research (NIDCR) )

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : June 30, 2020
  Estimated Study Completion Date : December 30, 2020